Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation | Zendy

Hedwig Kolve | Zendy; E. Ahlke | Zendy; W. Fegeler | Zendy; J. Ritter | Zendy; Heribert Jürgens | Zendy; Andreas H. Groll | Zendy

Open Access

Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation

Author(s) -

Hedwig Kolve,

E. Ahlke,

W. Fegeler,

J. Ritter,

Heribert Jürgens,

Andreas H. Groll

Publication year - 2009

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkp196

Subject(s) - medicine , transplantation , haematopoiesis , cancer , stem cell , amphotericin b , hematopoietic stem cell transplantation , oncology , hematopoietic cell , intensive care medicine , immunology , antifungal , biology , dermatology , genetics

To assess safety, tolerance and efficacy of liposomal amphotericin B (LAMB) in a large unselected series of paediatric cancer/haematopoietic stem cell transplantation (HSCT) patients requiring LAMB therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research